Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-AnalysisDan Rosmarin, Ian D. Tomlinson, Angela Jones et al.|Journal of Clinical Oncology|2014Cited by 261
Effect of pharmacogenetic-based selection of first-line chemotherapy on response rate and R0 surgery in metastatic CRC patients.Albert Abad, Eva Martinez‐Balibrea, José María Viéitez et al.|Journal of Clinical Oncology|2016Cited by 2